MindWalk Holdings Corp.
For the period ended Oct 21, 2026. Filed Oct 21, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Oct 21, 2026 · Filed Oct 21, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Availability
Availability
LensAI™ immunogenicity screening is commercially available from MindWalk. Amazon EC2 C8a and Hpc8a instances, powered by AMD EPYC™ processors, are available through Amazon Web Services.
The white paper, “Built to Inherit the Curve,” is available atwww.mindwalkai.com.
About MindWalk Holdings Corp.
MindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the BioIntelligence infrastructure that life sciences AI and agentic AI require, integrating AI, data, and advanced wet lab capabilities into one connected discovery ecosystem. At its core is HYFT® Technology, a proprietary, function-aware representation of biology. Its HYFT fingerprints span sequence and structural biology and, refined over 20 years of curation, form a continuously evolving biological representation of 660 million patterns and 25 billion relationships. This enriched biological representation is the architecture behind ReefIQ™, the biological data substrate that provides context for life sciences, enriching data at ingestion and growing more valuable with each program run on it, and LensAI™, the reasoning and application layer for target discovery, candidate diligence, portfolio decision support, and the agentic AI workflows pharma is racing to deploy. By design, value compounds in this HYFT representation layer, not in any individual AI model that runs on top of it.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.